BridgeMD
New treatment option for Infertility, Female
Official title SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques
ClinicalTrials.gov ID: NCT07175571
What this study is testing
- What it's testing
- The goal of this clinical trial is to learn whether two different methods of helping eggs and sperm join-intracytoplasmic sperm injection (ICSI) and conventional in vitro fertilization (IVF)-lead to better embryo development when using frozen donor sperm in people who do not have male fertility problems. The main questions it aims to answer are: Does one method create more usable embryos (blastocysts) than the other?
- Time commitment: about 12 months
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Adults, women only
You may be able to join if
- Female patients undergoing IVF with frozen donor sperm at Shady Grove Fertility Center
- Normal ovarian reserve (AMH \> 1 ng/mL, AFC \> 10)
- Absence of male factor infertility
- Post-wash parameters: \>50% motility, \>5mil concentration
- \> 4 oocytes retrieved at time of transvaginal oocyte retrieval
You likely can't join if
- Donor Sperm with significant male factor infertility (e.g., abnormal sperm concentration, motility, or morphology)
- Any medical condition contraindicating ART
The study team makes the final eligibility decision.
Where it's taking place
- Rockville, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 12 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling female, not specified. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rockville, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.